Naoko Iwamoto1, Hiromi Miyamoto2, Shinichiro Horiguchi3, Yayoi Honda2, Tomoyuki Aruga2. 1. Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. naoko-iwamoto@cick.jp. 2. Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. 3. Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Abstract
PURPOSE: The American College of Surgeons Oncology Group (ACOSOG) Z1071 trial assessed the accuracy of sentinel lymph node biopsies in clinically node-positive patients who underwent neoadjuvant chemotherapy (NAC). Axillary ultrasound (US) images after NAC were reviewed, and the accuracy of classifying nodes into six types according to the ACOSOG Z1071 trial was determined. METHODS: This study included 69 patients who underwent NAC followed by curative surgery for breast cancer including axillary lymph node dissection between January 2010 and July 2019. All patients were pathologically confirmed as being initially node positive. Lymph nodes were retrospectively classified into one of six types based on the appearance of the nodal cortex and hilum. Types I and II were classified as having normal nodal morphology, whereas types III, IV, V, and VI were classified as having suspicious nodal morphology. These node types on US images after NAC were compared between patients with an axillary complete response (Ax-pCR) and those with residual metastatic lymph nodes (Ax-non-pCR) using Chi-square tests. RESULTS: Twenty-four (35%) of the 69 patients achieved Ax-pCR. Patients with nodes classified as type I or II were more likely to achieve Ax-pCR (83% vs. 36%, p = 0. 0002). CONCLUSION: The classification of six node types was associated with nodal status.
PURPOSE: The American College of Surgeons Oncology Group (ACOSOG) Z1071 trial assessed the accuracy of sentinel lymph node biopsies in clinically node-positive patients who underwent neoadjuvant chemotherapy (NAC). Axillary ultrasound (US) images after NAC were reviewed, and the accuracy of classifying nodes into six types according to the ACOSOG Z1071 trial was determined. METHODS: This study included 69 patients who underwent NAC followed by curative surgery for breast cancer including axillary lymph node dissection between January 2010 and July 2019. All patients were pathologically confirmed as being initially node positive. Lymph nodes were retrospectively classified into one of six types based on the appearance of the nodal cortex and hilum. Types I and II were classified as having normal nodal morphology, whereas types III, IV, V, and VI were classified as having suspicious nodal morphology. These node types on US images after NAC were compared between patients with an axillary complete response (Ax-pCR) and those with residual metastatic lymph nodes (Ax-non-pCR) using Chi-square tests. RESULTS: Twenty-four (35%) of the 69 patients achieved Ax-pCR. Patients with nodes classified as type I or II were more likely to achieve Ax-pCR (83% vs. 36%, p = 0. 0002). CONCLUSION: The classification of six node types was associated with nodal status.
Authors: Hee Jun Choi; Jai Min Ryu; Isaac Kim; Seok Jin Nam; Seok Won Kim; Jonghan Yu; Jeong Eon Lee; Se Kyung Lee Journal: Breast Cancer Res Treat Date: 2019-05-07 Impact factor: 4.872
Authors: Jean-Francois Boileau; Brigitte Poirier; Mark Basik; Claire M B Holloway; Louis Gaboury; Lucas Sideris; Sarkis Meterissian; Angel Arnaout; Muriel Brackstone; David R McCready; Stephen E Karp; Isabelle Trop; Andre Lisbona; Frances C Wright; Rami J Younan; Louise Provencher; Erica Patocskai; Atilla Omeroglu; Andre Robidoux Journal: J Clin Oncol Date: 2014-12-01 Impact factor: 44.544
Authors: Robert-Jan Schipper; Martine Moossdorff; Patty J Nelemans; Grard A P Nieuwenhuijzen; Bart de Vries; Luc J A Strobbe; Rudi M H Roumen; Franchette van den Berkmortel; Vivianne C G Tjan-Heijnen; Regina G H Beets-Tan; Marc B I Lobbes; Marjolein L Smidt Journal: Clin Breast Cancer Date: 2014-01-03 Impact factor: 3.225
Authors: Huong T Le-Petross; Linda M McCall; Kelly K Hunt; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Karla V Ballman; Judy C Boughey Journal: AJR Am J Roentgenol Date: 2018-01-30 Impact factor: 3.959
Authors: Tina J Hieken; Judy C Boughey; Katie N Jones; Sejal S Shah; Katrina N Glazebrook Journal: Ann Surg Oncol Date: 2013-07-12 Impact factor: 5.344